However, similar to other chronic diseases such as T2D, the focus in obesity management (including pharmacotherapy prescription) over time will need to be shifted to primary care and collaborative integrated care models to be developed between specialist obesity services and primary care striving to meet the needs of people living with obesity [115]
Journal of Biomechanics, 2006
Seiwerth et al., Frontiers in Pharmacology (2021) and Xing et al., Int J Mol Sci (2021)
For some people with end-stage kidney disease, a kidney transplant may be the best treatment option
While berberine is generally well-tolerated at recommended doses, several safety considerations warrant attention
Glutathione: the master antioxidant Jul 20, 2020 2 min read by Dr